M

Michael C. Jensen

Seattle Children's Hospital

ORCID: 0000-0001-7477-3063

Publishes on CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction. 625 papers and 33.8k citations.

PubIndex Score98Top 2%How it's scored

625Publications

33.8kTotal Citations

First publication: 1970First senior author: 1991

CAR-T cell therapy research Immunotherapy and Immune Responses Immune Cell Function and Interaction Virus-based gene therapy research Monoclonal and Polyclonal Antibodies Research

Top publicationsby citations

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Christine E. Brown, Behnam Badie, Darya Alizadeh et al.|New England Journal of Medicine|2016

Cited by 1.8k

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

Rebecca Gardner, Michael C. Jensen|Blood|2017

Cited by 1.1k

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

Christine E. Brown, Michael C. Jensen, Jamie R. Wagner et al.|Clinical Cancer Research|2015

Cited by 754

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Brian G. Till, Oliver W. Press, Michael C. Jensen et al.|Blood|2008

Cited by 719

A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells

Xiuli Wang, Michael C. Jensen, Wen-Chung Chang et al.|Blood|2011

Cited by 600